CN Patent

CN104860891B — 芳氨基嘧啶类化合物及其应用以及由其制备的药物组合物和药用组合物

Assigned to Shanghai Hai Yan Pharmaceutical Technology Co Ltd · Expires 2017-06-30 · 9y expired

What this patent protects

本发明公开了一种对EGFR酪氨酸激酶具有抑制作用的芳氨基嘧啶类化合物及其药学上可接受的盐、立体异构体、溶剂化合物或前药，如式I所示，式中各基团的定义详见说明书。此外，本发明还公开了该化合物的药物组合物、药用组合物及其应用。

USPTO Abstract

本发明公开了一种对EGFR酪氨酸激酶具有抑制作用的芳氨基嘧啶类化合物及其药学上可接受的盐、立体异构体、溶剂化合物或前药，如式I所示，式中各基团的定义详见说明书。此外，本发明还公开了该化合物的药物组合物、药用组合物及其应用。

Drugs covered by this patent

Patent Metadata

Patent number
CN104860891B
Jurisdiction
CN
Classification
—
Expires
2017-06-30
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Hai Yan Pharmaceutical Technology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.